nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—Tacrolimus—atopic dermatitis	0.279	0.712	CbGbCtD
Auranofin—ALB—Prednisone—atopic dermatitis	0.113	0.289	CbGbCtD
Auranofin—Aplasia pure red cell—Tacrolimus—atopic dermatitis	0.0165	0.063	CcSEcCtD
Auranofin—Colitis ulcerative—Mometasone—atopic dermatitis	0.0134	0.0514	CcSEcCtD
Auranofin—PRDX5—neck—atopic dermatitis	0.0111	0.37	CbGeAlD
Auranofin—Loose stools—Pimecrolimus—atopic dermatitis	0.00897	0.0343	CcSEcCtD
Auranofin—PRDX5—skin of body—atopic dermatitis	0.00721	0.239	CbGeAlD
Auranofin—Loose stools—Tacrolimus—atopic dermatitis	0.00488	0.0187	CcSEcCtD
Auranofin—PRDX5—head—atopic dermatitis	0.0047	0.156	CbGeAlD
Auranofin—IKBKB—skin of body—atopic dermatitis	0.00427	0.142	CbGeAlD
Auranofin—Dermatitis exfoliative—Pimecrolimus—atopic dermatitis	0.00382	0.0146	CcSEcCtD
Auranofin—Interstitial lung disease—Tacrolimus—atopic dermatitis	0.00382	0.0146	CcSEcCtD
Auranofin—Proteinuria—Tacrolimus—atopic dermatitis	0.00308	0.0118	CcSEcCtD
Auranofin—Protein urine present—Tacrolimus—atopic dermatitis	0.00303	0.0116	CcSEcCtD
Auranofin—Neuropathy peripheral—Diphenhydramine—atopic dermatitis	0.00282	0.0108	CcSEcCtD
Auranofin—Neuropathy peripheral—Dimenhydrinate—atopic dermatitis	0.00282	0.0108	CcSEcCtD
Auranofin—IKBKB—head—atopic dermatitis	0.00278	0.0925	CbGeAlD
Auranofin—Conjunctivitis—Pimecrolimus—atopic dermatitis	0.0027	0.0103	CcSEcCtD
Auranofin—Agranulocytosis—Dimenhydrinate—atopic dermatitis	0.00268	0.0103	CcSEcCtD
Auranofin—Agranulocytosis—Diphenhydramine—atopic dermatitis	0.00268	0.0103	CcSEcCtD
Auranofin—Eye disorder—Pimecrolimus—atopic dermatitis	0.00233	0.00892	CcSEcCtD
Auranofin—Dermatitis exfoliative—Tacrolimus—atopic dermatitis	0.00208	0.00795	CcSEcCtD
Auranofin—Angioedema—Pimecrolimus—atopic dermatitis	0.00198	0.00759	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Tacrolimus—atopic dermatitis	0.00196	0.00751	CcSEcCtD
Auranofin—Conjunctivitis—Mometasone—atopic dermatitis	0.00185	0.00706	CcSEcCtD
Auranofin—Thrombocytopenia—Diphenhydramine—atopic dermatitis	0.00179	0.00687	CcSEcCtD
Auranofin—Thrombocytopenia—Dimenhydrinate—atopic dermatitis	0.00179	0.00687	CcSEcCtD
Auranofin—Pruritus—Desonide—atopic dermatitis	0.00177	0.00679	CcSEcCtD
Auranofin—Alopecia—Loratadine—atopic dermatitis	0.00176	0.00672	CcSEcCtD
Auranofin—Anorexia—Dimenhydrinate—atopic dermatitis	0.00175	0.00669	CcSEcCtD
Auranofin—Anorexia—Diphenhydramine—atopic dermatitis	0.00175	0.00669	CcSEcCtD
Auranofin—Visual impairment—Fluocinolone Acetonide—atopic dermatitis	0.00172	0.00658	CcSEcCtD
Auranofin—Dysphagia—Tacrolimus—atopic dermatitis	0.0017	0.00649	CcSEcCtD
Auranofin—Dysgeusia—Loratadine—atopic dermatitis	0.00169	0.00648	CcSEcCtD
Auranofin—Eye disorder—Fluocinolone Acetonide—atopic dermatitis	0.00167	0.00639	CcSEcCtD
Auranofin—Dyspepsia—Dimenhydrinate—atopic dermatitis	0.00161	0.00617	CcSEcCtD
Auranofin—Dyspepsia—Diphenhydramine—atopic dermatitis	0.00161	0.00617	CcSEcCtD
Auranofin—Pancytopenia—Tacrolimus—atopic dermatitis	0.00161	0.00616	CcSEcCtD
Auranofin—Decreased appetite—Dimenhydrinate—atopic dermatitis	0.00159	0.0061	CcSEcCtD
Auranofin—Decreased appetite—Diphenhydramine—atopic dermatitis	0.00159	0.0061	CcSEcCtD
Auranofin—Neutropenia—Tacrolimus—atopic dermatitis	0.00159	0.00607	CcSEcCtD
Auranofin—Rash—Desonide—atopic dermatitis	0.00158	0.00605	CcSEcCtD
Auranofin—Dermatitis—Desonide—atopic dermatitis	0.00158	0.00605	CcSEcCtD
Auranofin—Angioedema—Loratadine—atopic dermatitis	0.00158	0.00605	CcSEcCtD
Auranofin—Alopecia—Fluocinolone Acetonide—atopic dermatitis	0.00158	0.00604	CcSEcCtD
Auranofin—Constipation—Dimenhydrinate—atopic dermatitis	0.00157	0.006	CcSEcCtD
Auranofin—Constipation—Diphenhydramine—atopic dermatitis	0.00157	0.006	CcSEcCtD
Auranofin—Weight decreased—Tacrolimus—atopic dermatitis	0.00153	0.00587	CcSEcCtD
Auranofin—Dysgeusia—Fluocinolone Acetonide—atopic dermatitis	0.00152	0.00582	CcSEcCtD
Auranofin—Constipation—Pimecrolimus—atopic dermatitis	0.00152	0.0058	CcSEcCtD
Auranofin—Neuropathy peripheral—Tacrolimus—atopic dermatitis	0.00148	0.00567	CcSEcCtD
Auranofin—Stomatitis—Tacrolimus—atopic dermatitis	0.00147	0.00564	CcSEcCtD
Auranofin—Jaundice—Tacrolimus—atopic dermatitis	0.00147	0.00564	CcSEcCtD
Auranofin—Conjunctivitis—Tacrolimus—atopic dermatitis	0.00147	0.00562	CcSEcCtD
Auranofin—Urticaria—Dimenhydrinate—atopic dermatitis	0.00146	0.00557	CcSEcCtD
Auranofin—Urticaria—Diphenhydramine—atopic dermatitis	0.00146	0.00557	CcSEcCtD
Auranofin—Gastrointestinal pain—Pimecrolimus—atopic dermatitis	0.00145	0.00555	CcSEcCtD
Auranofin—Haematuria—Tacrolimus—atopic dermatitis	0.00144	0.00552	CcSEcCtD
Auranofin—Pruritus—Fluocinonide—atopic dermatitis	0.00144	0.0055	CcSEcCtD
Auranofin—Agranulocytosis—Tacrolimus—atopic dermatitis	0.00141	0.0054	CcSEcCtD
Auranofin—Urticaria—Pimecrolimus—atopic dermatitis	0.00141	0.00539	CcSEcCtD
Auranofin—Abdominal pain—Pimecrolimus—atopic dermatitis	0.0014	0.00536	CcSEcCtD
Auranofin—Angioedema—Mometasone—atopic dermatitis	0.00136	0.00519	CcSEcCtD
Auranofin—Visual impairment—Tacrolimus—atopic dermatitis	0.00131	0.005	CcSEcCtD
Auranofin—Rash—Fluocinonide—atopic dermatitis	0.00128	0.0049	CcSEcCtD
Auranofin—Dermatitis—Fluocinonide—atopic dermatitis	0.00128	0.0049	CcSEcCtD
Auranofin—Eye disorder—Tacrolimus—atopic dermatitis	0.00127	0.00485	CcSEcCtD
Auranofin—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.00125	0.0048	CcSEcCtD
Auranofin—Diarrhoea—Diphenhydramine—atopic dermatitis	0.00125	0.0048	CcSEcCtD
Auranofin—Pruritus—Pimecrolimus—atopic dermatitis	0.00125	0.0048	CcSEcCtD
Auranofin—Dyspepsia—Loratadine—atopic dermatitis	0.00124	0.00475	CcSEcCtD
Auranofin—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00121	0.00464	CcSEcCtD
Auranofin—Constipation—Loratadine—atopic dermatitis	0.00121	0.00462	CcSEcCtD
Auranofin—Alopecia—Tacrolimus—atopic dermatitis	0.0012	0.00459	CcSEcCtD
Auranofin—Vomiting—Diphenhydramine—atopic dermatitis	0.00117	0.00446	CcSEcCtD
Auranofin—Vomiting—Dimenhydrinate—atopic dermatitis	0.00117	0.00446	CcSEcCtD
Auranofin—Flatulence—Tacrolimus—atopic dermatitis	0.00116	0.00445	CcSEcCtD
Auranofin—Dysgeusia—Tacrolimus—atopic dermatitis	0.00116	0.00443	CcSEcCtD
Auranofin—Rash—Dimenhydrinate—atopic dermatitis	0.00116	0.00442	CcSEcCtD
Auranofin—Rash—Diphenhydramine—atopic dermatitis	0.00116	0.00442	CcSEcCtD
Auranofin—Anorexia—Mometasone—atopic dermatitis	0.00115	0.00442	CcSEcCtD
Auranofin—Dermatitis—Diphenhydramine—atopic dermatitis	0.00115	0.00442	CcSEcCtD
Auranofin—Dermatitis—Dimenhydrinate—atopic dermatitis	0.00115	0.00442	CcSEcCtD
Auranofin—Gastrointestinal pain—Loratadine—atopic dermatitis	0.00115	0.00442	CcSEcCtD
Auranofin—Vomiting—Pimecrolimus—atopic dermatitis	0.00113	0.00431	CcSEcCtD
Auranofin—Rash—Pimecrolimus—atopic dermatitis	0.00112	0.00428	CcSEcCtD
Auranofin—Dermatitis—Pimecrolimus—atopic dermatitis	0.00112	0.00427	CcSEcCtD
Auranofin—Abdominal pain—Loratadine—atopic dermatitis	0.00112	0.00427	CcSEcCtD
Auranofin—Anaemia—Tacrolimus—atopic dermatitis	0.00109	0.00418	CcSEcCtD
Auranofin—Nausea—Dimenhydrinate—atopic dermatitis	0.00109	0.00417	CcSEcCtD
Auranofin—Nausea—Diphenhydramine—atopic dermatitis	0.00109	0.00417	CcSEcCtD
Auranofin—Dyspepsia—Mometasone—atopic dermatitis	0.00107	0.00408	CcSEcCtD
Auranofin—Leukopenia—Tacrolimus—atopic dermatitis	0.00106	0.00405	CcSEcCtD
Auranofin—Decreased appetite—Mometasone—atopic dermatitis	0.00105	0.00403	CcSEcCtD
Auranofin—Nausea—Pimecrolimus—atopic dermatitis	0.00105	0.00403	CcSEcCtD
Auranofin—IKBKB—p75(NTR)-mediated signaling—NGF—atopic dermatitis	0.00105	0.00332	CbGpPWpGaD
Auranofin—IKBKB—IL1-mediated signaling events—IL1B—atopic dermatitis	0.00105	0.0033	CbGpPWpGaD
Auranofin—IKBKB—IL-1 signaling pathway—NFKBIA—atopic dermatitis	0.00104	0.00328	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—NFKBIA—atopic dermatitis	0.00104	0.00328	CbGpPWpGaD
Auranofin—IKBKB—Canonical NF-kappaB pathway—TNF—atopic dermatitis	0.00104	0.00327	CbGpPWpGaD
Auranofin—IKBKB—EBV LMP1 signaling—TNF—atopic dermatitis	0.00104	0.00327	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CARD11—atopic dermatitis	0.00103	0.00326	CbGpPWpGaD
Auranofin—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP8—atopic dermatitis	0.00101	0.0032	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—TLR2—atopic dermatitis	0.000995	0.00314	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000991	0.00379	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—CARD11—atopic dermatitis	0.000987	0.00311	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling—NFKBIA—atopic dermatitis	0.000984	0.0031	CbGpPWpGaD
Auranofin—IKBKB—Downstream TCR signaling—CD4—atopic dermatitis	0.000975	0.00308	CbGpPWpGaD
Auranofin—Diarrhoea—Loratadine—atopic dermatitis	0.000966	0.0037	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—CXCL10—atopic dermatitis	0.000966	0.00305	CbGpPWpGaD
Auranofin—IKBKB—IL1-mediated signaling events—MAPK8—atopic dermatitis	0.000959	0.00303	CbGpPWpGaD
Auranofin—Abdominal pain—Mometasone—atopic dermatitis	0.000958	0.00366	CcSEcCtD
Auranofin—Weight decreased—Hydrocortisone—atopic dermatitis	0.000957	0.00366	CcSEcCtD
Auranofin—Neuropathy peripheral—Prednisolone—atopic dermatitis	0.000946	0.00362	CcSEcCtD
Auranofin—Thrombocytopenia—Tacrolimus—atopic dermatitis	0.000944	0.00361	CcSEcCtD
Auranofin—Conjunctivitis—Prednisolone—atopic dermatitis	0.000939	0.00359	CcSEcCtD
Auranofin—IKBKB—FAS (CD95) signaling pathway—MAPK8—atopic dermatitis	0.000937	0.00296	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—TLR2—atopic dermatitis	0.000936	0.00295	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—IL6—atopic dermatitis	0.000932	0.00294	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Hydrocortisone—atopic dermatitis	0.000924	0.00354	CcSEcCtD
Auranofin—Anorexia—Tacrolimus—atopic dermatitis	0.000919	0.00352	CcSEcCtD
Auranofin—IKBKB—Interleukin-1 signaling—IL1B—atopic dermatitis	0.000918	0.0029	CbGpPWpGaD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—NGF—atopic dermatitis	0.000917	0.00289	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—CARD11—atopic dermatitis	0.000913	0.00288	CbGpPWpGaD
Auranofin—IKBKB—Activation of NF-kappaB in B cells—NFKBIA—atopic dermatitis	0.00091	0.00287	CbGpPWpGaD
Auranofin—Gastrointestinal haemorrhage—Prednisone—atopic dermatitis	0.00091	0.00348	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—CD8A—atopic dermatitis	0.000905	0.00286	CbGpPWpGaD
Auranofin—IKBKB—NOD pathway—IL1B—atopic dermatitis	0.000901	0.00284	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—NFKBIA—atopic dermatitis	0.000899	0.00284	CbGpPWpGaD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—NFKBIA—atopic dermatitis	0.000899	0.00284	CbGpPWpGaD
Auranofin—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000897	0.00343	CcSEcCtD
Auranofin—Vomiting—Loratadine—atopic dermatitis	0.000897	0.00343	CcSEcCtD
Auranofin—Rash—Loratadine—atopic dermatitis	0.00089	0.00341	CcSEcCtD
Auranofin—Dermatitis—Loratadine—atopic dermatitis	0.000889	0.0034	CcSEcCtD
Auranofin—IKBKB—BCR signaling pathway—NFKBIA—atopic dermatitis	0.000889	0.0028	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NFKBIA—atopic dermatitis	0.000889	0.0028	CbGpPWpGaD
Auranofin—Neuropathy peripheral—Triamcinolone—atopic dermatitis	0.00087	0.00333	CcSEcCtD
Auranofin—Neuropathy peripheral—Methylprednisolone—atopic dermatitis	0.000868	0.00332	CcSEcCtD
Auranofin—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000868	0.00332	CcSEcCtD
Auranofin—Conjunctivitis—Triamcinolone—atopic dermatitis	0.000863	0.0033	CcSEcCtD
Auranofin—Pruritus—Mometasone—atopic dermatitis	0.000857	0.00328	CcSEcCtD
Auranofin—Dyspepsia—Tacrolimus—atopic dermatitis	0.000849	0.00325	CcSEcCtD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TLR2—atopic dermatitis	0.000843	0.00266	CbGpPWpGaD
Auranofin—Nausea—Loratadine—atopic dermatitis	0.000838	0.00321	CcSEcCtD
Auranofin—Decreased appetite—Tacrolimus—atopic dermatitis	0.000838	0.00321	CcSEcCtD
Auranofin—Visual impairment—Prednisolone—atopic dermatitis	0.000835	0.0032	CcSEcCtD
Auranofin—IKBKB—Toll-Like Receptors Cascades—TLR2—atopic dermatitis	0.000834	0.00263	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—CCL5—atopic dermatitis	0.000831	0.00262	CbGpPWpGaD
Auranofin—Diarrhoea—Mometasone—atopic dermatitis	0.000829	0.00317	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—CCR5—atopic dermatitis	0.000828	0.00261	CbGpPWpGaD
Auranofin—Constipation—Tacrolimus—atopic dermatitis	0.000824	0.00315	CcSEcCtD
Auranofin—Weight decreased—Betamethasone—atopic dermatitis	0.000817	0.00313	CcSEcCtD
Auranofin—Weight decreased—Dexamethasone—atopic dermatitis	0.000817	0.00313	CcSEcCtD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—NFKBIA—atopic dermatitis	0.000812	0.00256	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—CASP8—atopic dermatitis	0.000811	0.00256	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—MAPK8—atopic dermatitis	0.00081	0.00256	CbGpPWpGaD
Auranofin—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000807	0.00309	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—CASP1—atopic dermatitis	0.000801	0.00253	CbGpPWpGaD
Auranofin—Rash—Fluocinolone Acetonide—atopic dermatitis	0.0008	0.00306	CcSEcCtD
Auranofin—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000799	0.00306	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—IL18—atopic dermatitis	0.000794	0.00251	CbGpPWpGaD
Auranofin—Eye disorder—Hydrocortisone—atopic dermatitis	0.000791	0.00303	CcSEcCtD
Auranofin—Neuropathy peripheral—Dexamethasone—atopic dermatitis	0.00079	0.00302	CcSEcCtD
Auranofin—Neuropathy peripheral—Betamethasone—atopic dermatitis	0.00079	0.00302	CcSEcCtD
Auranofin—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000788	0.00302	CcSEcCtD
Auranofin—Conjunctivitis—Dexamethasone—atopic dermatitis	0.000783	0.003	CcSEcCtD
Auranofin—Conjunctivitis—Betamethasone—atopic dermatitis	0.000783	0.003	CcSEcCtD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—NFKBIA—atopic dermatitis	0.000771	0.00243	CbGpPWpGaD
Auranofin—Vomiting—Mometasone—atopic dermatitis	0.00077	0.00295	CcSEcCtD
Auranofin—Visual impairment—Methylprednisolone—atopic dermatitis	0.000766	0.00293	CcSEcCtD
Auranofin—Urticaria—Tacrolimus—atopic dermatitis	0.000766	0.00293	CcSEcCtD
Auranofin—ALB—Vitamin B12 Metabolism—CCL5—atopic dermatitis	0.000765	0.00241	CbGpPWpGaD
Auranofin—Rash—Mometasone—atopic dermatitis	0.000764	0.00292	CcSEcCtD
Auranofin—Dermatitis—Mometasone—atopic dermatitis	0.000763	0.00292	CcSEcCtD
Auranofin—Abdominal pain—Tacrolimus—atopic dermatitis	0.000762	0.00292	CcSEcCtD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—NFKBIA—atopic dermatitis	0.000756	0.00239	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CXCL10—atopic dermatitis	0.000754	0.00238	CbGpPWpGaD
Auranofin—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000753	0.00288	CcSEcCtD
Auranofin—Eye disorder—Methylprednisolone—atopic dermatitis	0.000743	0.00284	CcSEcCtD
Auranofin—IKBKB—Apoptosis—NFKBIA—atopic dermatitis	0.000742	0.00234	CbGpPWpGaD
Auranofin—IKBKB—Structural Pathway of Interleukin 1 (IL-1)—MAPK8—atopic dermatitis	0.00074	0.00234	CbGpPWpGaD
Auranofin—Neutropenia—Prednisone—atopic dermatitis	0.000736	0.00282	CcSEcCtD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—NFKBIA—atopic dermatitis	0.000735	0.00232	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling—CD4—atopic dermatitis	0.000729	0.0023	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKBIA—atopic dermatitis	0.000728	0.0023	CbGpPWpGaD
Auranofin—Nausea—Mometasone—atopic dermatitis	0.000719	0.00275	CcSEcCtD
Auranofin—IKBKB—FoxO family signaling—MAPK8—atopic dermatitis	0.000716	0.00226	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—NFKBIA—atopic dermatitis	0.000714	0.00225	CbGpPWpGaD
Auranofin—IKBKB—IL-1 signaling pathway—IL1B—atopic dermatitis	0.000712	0.00225	CbGpPWpGaD
Auranofin—Weight decreased—Prednisone—atopic dermatitis	0.000712	0.00272	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.000702	0.00221	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FCER1A—atopic dermatitis	0.0007	0.00221	CbGpPWpGaD
Auranofin—Visual impairment—Betamethasone—atopic dermatitis	0.000697	0.00267	CcSEcCtD
Auranofin—Visual impairment—Dexamethasone—atopic dermatitis	0.000697	0.00267	CcSEcCtD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—NFKBIA—atopic dermatitis	0.000696	0.00219	CbGpPWpGaD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CASP8—atopic dermatitis	0.000696	0.00219	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—NFKBIA—atopic dermatitis	0.00069	0.00218	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—NFKBIA—atopic dermatitis	0.00069	0.00218	CbGpPWpGaD
Auranofin—Angioedema—Prednisolone—atopic dermatitis	0.000689	0.00264	CcSEcCtD
Auranofin—Neuropathy peripheral—Prednisone—atopic dermatitis	0.000688	0.00263	CcSEcCtD
Auranofin—Pruritus—Tacrolimus—atopic dermatitis	0.000682	0.00261	CcSEcCtD
Auranofin—Dysgeusia—Triamcinolone—atopic dermatitis	0.000679	0.0026	CcSEcCtD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—NFKBIA—atopic dermatitis	0.000678	0.00214	CbGpPWpGaD
Auranofin—Eye disorder—Betamethasone—atopic dermatitis	0.000676	0.00259	CcSEcCtD
Auranofin—Eye disorder—Dexamethasone—atopic dermatitis	0.000676	0.00259	CcSEcCtD
Auranofin—Angioedema—Hydrocortisone—atopic dermatitis	0.000673	0.00258	CcSEcCtD
Auranofin—IKBKB—Apoptosis—CASP8—atopic dermatitis	0.000669	0.00211	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—atopic dermatitis	0.000666	0.0021	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—NFKBIA—atopic dermatitis	0.000661	0.00209	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTSE—atopic dermatitis	0.00066	0.00208	CbGpPWpGaD
Auranofin—Diarrhoea—Tacrolimus—atopic dermatitis	0.00066	0.00252	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—BDNF—atopic dermatitis	0.000658	0.00208	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—MAPK8—atopic dermatitis	0.000653	0.00206	CbGpPWpGaD
Auranofin—IKBKB—IL-1 signaling pathway—MAPK8—atopic dermatitis	0.000653	0.00206	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—MAPK8—atopic dermatitis	0.000653	0.00206	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MS4A2—atopic dermatitis	0.00065	0.00205	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—NFKBIA—atopic dermatitis	0.00065	0.00205	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CCL5—atopic dermatitis	0.000649	0.00205	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—TNF—atopic dermatitis	0.000641	0.00202	CbGpPWpGaD
Auranofin—Alopecia—Betamethasone—atopic dermatitis	0.000639	0.00245	CcSEcCtD
Auranofin—Alopecia—Dexamethasone—atopic dermatitis	0.000639	0.00245	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—NFKBIA—atopic dermatitis	0.000635	0.002	CbGpPWpGaD
Auranofin—Angioedema—Triamcinolone—atopic dermatitis	0.000634	0.00243	CcSEcCtD
Auranofin—Angioedema—Methylprednisolone—atopic dermatitis	0.000633	0.00242	CcSEcCtD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CASP8—atopic dermatitis	0.000627	0.00198	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—CASP8—atopic dermatitis	0.000622	0.00196	CbGpPWpGaD
Auranofin—Vomiting—Tacrolimus—atopic dermatitis	0.000613	0.00235	CcSEcCtD
Auranofin—Rash—Tacrolimus—atopic dermatitis	0.000608	0.00233	CcSEcCtD
Auranofin—Dermatitis—Tacrolimus—atopic dermatitis	0.000607	0.00232	CcSEcCtD
Auranofin—IKBKB—B Cell Activation—CD79A—atopic dermatitis	0.000605	0.00191	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL4—atopic dermatitis	0.000603	0.0019	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—MAPK8—atopic dermatitis	0.000601	0.0019	CbGpPWpGaD
Auranofin—IKBKB—TNF receptor signaling pathway —TNF—atopic dermatitis	0.000596	0.00188	CbGpPWpGaD
Auranofin—Eye disorder—Prednisone—atopic dermatitis	0.000589	0.00225	CcSEcCtD
Auranofin—IKBKB—MyD88-independent cascade—CASP8—atopic dermatitis	0.000587	0.00185	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—NFKBIA—atopic dermatitis	0.000585	0.00185	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—NGF—atopic dermatitis	0.000584	0.00184	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—BDNF—atopic dermatitis	0.000582	0.00184	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—DEFB1—atopic dermatitis	0.00058	0.00183	CbGpPWpGaD
Auranofin—Angioedema—Betamethasone—atopic dermatitis	0.000575	0.0022	CcSEcCtD
Auranofin—Angioedema—Dexamethasone—atopic dermatitis	0.000575	0.0022	CcSEcCtD
Auranofin—Anorexia—Hydrocortisone—atopic dermatitis	0.000573	0.00219	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—CASP8—atopic dermatitis	0.000573	0.00181	CbGpPWpGaD
Auranofin—Nausea—Tacrolimus—atopic dermatitis	0.000573	0.00219	CcSEcCtD
Auranofin—IKBKB—AGE/RAGE pathway—MAPK8—atopic dermatitis	0.000564	0.00178	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—MAPK8—atopic dermatitis	0.000557	0.00176	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—MAPK8—atopic dermatitis	0.000557	0.00176	CbGpPWpGaD
Auranofin—Alopecia—Prednisone—atopic dermatitis	0.000557	0.00213	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—IL1B—atopic dermatitis	0.000555	0.00175	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—NFKBIA—atopic dermatitis	0.00055	0.00174	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—MAPK8—atopic dermatitis	0.000544	0.00172	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—CASP1—atopic dermatitis	0.000533	0.00168	CbGpPWpGaD
Auranofin—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000529	0.00203	CcSEcCtD
Auranofin—IKBKB—Activated TLR4 signalling—CASP8—atopic dermatitis	0.000528	0.00166	CbGpPWpGaD
Auranofin—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000523	0.002	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—CD4—atopic dermatitis	0.00052	0.00164	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—IL6—atopic dermatitis	0.000517	0.00163	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TNF—atopic dermatitis	0.000517	0.00163	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—NGF—atopic dermatitis	0.000516	0.00163	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000513	0.00162	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—MAPK8—atopic dermatitis	0.000509	0.00161	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—MAPK8—atopic dermatitis	0.000509	0.00161	CbGpPWpGaD
Auranofin—Anaemia—Prednisone—atopic dermatitis	0.000507	0.00194	CcSEcCtD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL5—atopic dermatitis	0.000505	0.00159	CbGpPWpGaD
Auranofin—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000503	0.00193	CcSEcCtD
Auranofin—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000503	0.00193	CcSEcCtD
Auranofin—Angioedema—Prednisone—atopic dermatitis	0.000501	0.00192	CcSEcCtD
Auranofin—Dyspepsia—Triamcinolone—atopic dermatitis	0.000498	0.00191	CcSEcCtD
Auranofin—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000497	0.0019	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—CASP8—atopic dermatitis	0.000496	0.00157	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—NFKBIA—atopic dermatitis	0.000496	0.00156	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000492	0.00188	CcSEcCtD
Auranofin—IKBKB—Toll-Like Receptors Cascades—NFKBIA—atopic dermatitis	0.00049	0.00155	CbGpPWpGaD
Auranofin—Anorexia—Betamethasone—atopic dermatitis	0.00049	0.00187	CcSEcCtD
Auranofin—Anorexia—Dexamethasone—atopic dermatitis	0.00049	0.00187	CcSEcCtD
Auranofin—Urticaria—Prednisolone—atopic dermatitis	0.000489	0.00187	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—NFKBIA—atopic dermatitis	0.000482	0.00152	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL1B—atopic dermatitis	0.00048	0.00151	CbGpPWpGaD
Auranofin—Urticaria—Hydrocortisone—atopic dermatitis	0.000478	0.00183	CcSEcCtD
Auranofin—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000475	0.00182	CcSEcCtD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—MAPK8—atopic dermatitis	0.000474	0.0015	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—MAPK8—atopic dermatitis	0.000465	0.00147	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000462	0.00177	CcSEcCtD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—MAPK8—atopic dermatitis	0.000461	0.00145	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK8—atopic dermatitis	0.000457	0.00144	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—CXCL8—atopic dermatitis	0.000453	0.00143	CbGpPWpGaD
Auranofin—Dyspepsia—Dexamethasone—atopic dermatitis	0.000452	0.00173	CcSEcCtD
Auranofin—Dyspepsia—Betamethasone—atopic dermatitis	0.000452	0.00173	CcSEcCtD
Auranofin—Urticaria—Triamcinolone—atopic dermatitis	0.00045	0.00172	CcSEcCtD
Auranofin—Urticaria—Methylprednisolone—atopic dermatitis	0.000449	0.00172	CcSEcCtD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—MAPK8—atopic dermatitis	0.000448	0.00141	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.000448	0.00141	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CASP8—atopic dermatitis	0.000447	0.00141	CbGpPWpGaD
Auranofin—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000447	0.00171	CcSEcCtD
Auranofin—Decreased appetite—Betamethasone—atopic dermatitis	0.000447	0.00171	CcSEcCtD
Auranofin—Decreased appetite—Dexamethasone—atopic dermatitis	0.000447	0.00171	CcSEcCtD
Auranofin—IKBKB—Adaptive Immune System—KIF3A—atopic dermatitis	0.000445	0.0014	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—CASP8—atopic dermatitis	0.000442	0.00139	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.00044	0.00139	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—MAPK8—atopic dermatitis	0.000436	0.00138	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL1B—atopic dermatitis	0.000434	0.00137	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—MAPK8—atopic dermatitis	0.000433	0.00136	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—MAPK8—atopic dermatitis	0.000433	0.00136	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NFKBIA—atopic dermatitis	0.000428	0.00135	CbGpPWpGaD
Auranofin—Anorexia—Prednisone—atopic dermatitis	0.000427	0.00163	CcSEcCtD
Auranofin—Pruritus—Hydrocortisone—atopic dermatitis	0.000425	0.00163	CcSEcCtD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—MAPK8—atopic dermatitis	0.000425	0.00134	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.00042	0.00161	CcSEcCtD
Auranofin—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.00042	0.00161	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—IL1B—atopic dermatitis	0.000415	0.00131	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—MAPK8—atopic dermatitis	0.000415	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL2—atopic dermatitis	0.000413	0.0013	CbGpPWpGaD
Auranofin—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000411	0.00157	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—NFKBIA—atopic dermatitis	0.000409	0.00129	CbGpPWpGaD
Auranofin—Urticaria—Dexamethasone—atopic dermatitis	0.000408	0.00156	CcSEcCtD
Auranofin—Urticaria—Betamethasone—atopic dermatitis	0.000408	0.00156	CcSEcCtD
Auranofin—IKBKB—MyD88-independent cascade—MAPK8—atopic dermatitis	0.000408	0.00129	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FCER1A—atopic dermatitis	0.000408	0.00129	CbGpPWpGaD
Auranofin—Abdominal pain—Betamethasone—atopic dermatitis	0.000406	0.00155	CcSEcCtD
Auranofin—Abdominal pain—Dexamethasone—atopic dermatitis	0.000406	0.00155	CcSEcCtD
Auranofin—Pruritus—Triamcinolone—atopic dermatitis	0.000401	0.00153	CcSEcCtD
Auranofin—Pruritus—Methylprednisolone—atopic dermatitis	0.0004	0.00153	CcSEcCtD
Auranofin—ALB—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.0004	0.00126	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—MAPK8—atopic dermatitis	0.000398	0.00126	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—STAT6—atopic dermatitis	0.000394	0.00124	CbGpPWpGaD
Auranofin—Dyspepsia—Prednisone—atopic dermatitis	0.000394	0.00151	CcSEcCtD
Auranofin—Decreased appetite—Prednisone—atopic dermatitis	0.000389	0.00149	CcSEcCtD
Auranofin—Rash—Prednisolone—atopic dermatitis	0.000388	0.00149	CcSEcCtD
Auranofin—Dermatitis—Prednisolone—atopic dermatitis	0.000388	0.00148	CcSEcCtD
Auranofin—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000387	0.00148	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—CASP8—atopic dermatitis	0.000384	0.00121	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CARD11—atopic dermatitis	0.000383	0.00121	CbGpPWpGaD
Auranofin—Constipation—Prednisone—atopic dermatitis	0.000383	0.00146	CcSEcCtD
Auranofin—Vomiting—Hydrocortisone—atopic dermatitis	0.000382	0.00146	CcSEcCtD
Auranofin—Rash—Hydrocortisone—atopic dermatitis	0.000379	0.00145	CcSEcCtD
Auranofin—IKBKB—Immune System—MS4A2—atopic dermatitis	0.000379	0.0012	CbGpPWpGaD
Auranofin—Dermatitis—Hydrocortisone—atopic dermatitis	0.000379	0.00145	CcSEcCtD
Auranofin—IKBKB—B Cell Activation—NFKBIA—atopic dermatitis	0.000378	0.00119	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL18—atopic dermatitis	0.000371	0.00117	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.000371	0.00117	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CARD11—atopic dermatitis	0.000368	0.00116	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—atopic dermatitis	0.000368	0.00116	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TNF—atopic dermatitis	0.000368	0.00116	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—MAPK8—atopic dermatitis	0.000367	0.00116	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000366	0.0014	CcSEcCtD
Auranofin—Nausea—Prednisolone—atopic dermatitis	0.000366	0.0014	CcSEcCtD
Auranofin—ALB—Folate Metabolism—IFNG—atopic dermatitis	0.000365	0.00115	CbGpPWpGaD
Auranofin—Pruritus—Betamethasone—atopic dermatitis	0.000364	0.00139	CcSEcCtD
Auranofin—Pruritus—Dexamethasone—atopic dermatitis	0.000364	0.00139	CcSEcCtD
Auranofin—Vomiting—Triamcinolone—atopic dermatitis	0.00036	0.00138	CcSEcCtD
Auranofin—Vomiting—Methylprednisolone—atopic dermatitis	0.000359	0.00137	CcSEcCtD
Auranofin—Nausea—Hydrocortisone—atopic dermatitis	0.000357	0.00137	CcSEcCtD
Auranofin—Rash—Triamcinolone—atopic dermatitis	0.000357	0.00137	CcSEcCtD
Auranofin—Dermatitis—Triamcinolone—atopic dermatitis	0.000357	0.00137	CcSEcCtD
Auranofin—Rash—Methylprednisolone—atopic dermatitis	0.000356	0.00136	CcSEcCtD
Auranofin—Dermatitis—Methylprednisolone—atopic dermatitis	0.000356	0.00136	CcSEcCtD
Auranofin—Urticaria—Prednisone—atopic dermatitis	0.000355	0.00136	CcSEcCtD
Auranofin—Abdominal pain—Prednisone—atopic dermatitis	0.000354	0.00135	CcSEcCtD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	0.000353	0.00112	CbGpPWpGaD
Auranofin—Diarrhoea—Betamethasone—atopic dermatitis	0.000352	0.00135	CcSEcCtD
Auranofin—Diarrhoea—Dexamethasone—atopic dermatitis	0.000352	0.00135	CcSEcCtD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—atopic dermatitis	0.000345	0.00109	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—TNF—atopic dermatitis	0.000342	0.00108	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	0.000339	0.00107	CbGpPWpGaD
Auranofin—IKBKB—Immune System—DEFB1—atopic dermatitis	0.000338	0.00107	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NGF—atopic dermatitis	0.000337	0.00106	CbGpPWpGaD
Auranofin—Nausea—Triamcinolone—atopic dermatitis	0.000336	0.00129	CcSEcCtD
Auranofin—Nausea—Methylprednisolone—atopic dermatitis	0.000336	0.00128	CcSEcCtD
Auranofin—Vomiting—Betamethasone—atopic dermatitis	0.000327	0.00125	CcSEcCtD
Auranofin—Vomiting—Dexamethasone—atopic dermatitis	0.000327	0.00125	CcSEcCtD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—atopic dermatitis	0.000325	0.00103	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL1B—atopic dermatitis	0.000325	0.00103	CbGpPWpGaD
Auranofin—Rash—Betamethasone—atopic dermatitis	0.000324	0.00124	CcSEcCtD
Auranofin—Rash—Dexamethasone—atopic dermatitis	0.000324	0.00124	CcSEcCtD
Auranofin—ALB—Folate Metabolism—IL2—atopic dermatitis	0.000324	0.00102	CbGpPWpGaD
Auranofin—Dermatitis—Dexamethasone—atopic dermatitis	0.000324	0.00124	CcSEcCtD
Auranofin—Dermatitis—Betamethasone—atopic dermatitis	0.000324	0.00124	CcSEcCtD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.000322	0.00102	CbGpPWpGaD
Auranofin—Pruritus—Prednisone—atopic dermatitis	0.000317	0.00121	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TNF—atopic dermatitis	0.000315	0.000994	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	0.000311	0.000981	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	0.000307	0.00097	CbGpPWpGaD
Auranofin—Diarrhoea—Prednisone—atopic dermatitis	0.000306	0.00117	CcSEcCtD
Auranofin—Nausea—Dexamethasone—atopic dermatitis	0.000305	0.00117	CcSEcCtD
Auranofin—Nausea—Betamethasone—atopic dermatitis	0.000305	0.00117	CcSEcCtD
Auranofin—IKBKB—BDNF signaling pathway—MAPK8—atopic dermatitis	0.000302	0.000954	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CASP1—atopic dermatitis	0.000299	0.000942	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000296	0.000933	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	0.000294	0.000929	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	0.000292	0.00092	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—IL1B—atopic dermatitis	0.000291	0.000919	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—TNF—atopic dermatitis	0.00029	0.000915	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.00029	0.000914	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	0.000286	0.000903	CbGpPWpGaD
Auranofin—Vomiting—Prednisone—atopic dermatitis	0.000285	0.00109	CcSEcCtD
Auranofin—Rash—Prednisone—atopic dermatitis	0.000282	0.00108	CcSEcCtD
Auranofin—Dermatitis—Prednisone—atopic dermatitis	0.000282	0.00108	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—IL6—atopic dermatitis	0.000281	0.000887	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NFKBIA—atopic dermatitis	0.000278	0.000878	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—MAPK8—atopic dermatitis	0.000278	0.000877	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—IL6—atopic dermatitis	0.000276	0.000872	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	0.000276	0.000872	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KIF3A—atopic dermatitis	0.000272	0.000859	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	0.000272	0.000857	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TLR2—atopic dermatitis	0.00027	0.000852	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KIF3A—atopic dermatitis	0.00027	0.000852	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MAPK8—atopic dermatitis	0.000267	0.000843	CbGpPWpGaD
Auranofin—Nausea—Prednisone—atopic dermatitis	0.000266	0.00102	CcSEcCtD
Auranofin—IKBKB—Signaling Pathways—FCER2—atopic dermatitis	0.000263	0.000831	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—IL6—atopic dermatitis	0.00026	0.000822	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000258	0.000815	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	0.000256	0.000809	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	0.000254	0.000802	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	0.000246	0.000776	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL22—atopic dermatitis	0.000245	0.000773	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD79A—atopic dermatitis	0.000244	0.000769	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—atopic dermatitis	0.000243	0.000767	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—atopic dermatitis	0.000236	0.000745	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—atopic dermatitis	0.000234	0.000739	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—atopic dermatitis	0.000234	0.000738	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT6—atopic dermatitis	0.00023	0.000724	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CARD11—atopic dermatitis	0.000223	0.000705	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	0.00022	0.000695	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SELE—atopic dermatitis	0.000219	0.000692	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL27—atopic dermatitis	0.000218	0.000689	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IFNG—atopic dermatitis	0.000217	0.000685	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—atopic dermatitis	0.000211	0.000667	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	0.000199	0.000626	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD8A—atopic dermatitis	0.000197	0.00062	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—atopic dermatitis	0.000196	0.000619	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL17—atopic dermatitis	0.000196	0.000618	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	0.000194	0.000611	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL2—atopic dermatitis	0.000193	0.000609	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—atopic dermatitis	0.00019	0.000601	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000188	0.000594	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—atopic dermatitis	0.000187	0.000591	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK8—atopic dermatitis	0.000175	0.000551	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KIF3A—atopic dermatitis	0.000175	0.000551	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CASP1—atopic dermatitis	0.000174	0.000549	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL5—atopic dermatitis	0.000166	0.000524	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL5—atopic dermatitis	0.000165	0.00052	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	0.000164	0.000516	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NFKBIA—atopic dermatitis	0.000159	0.000501	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CMA1—atopic dermatitis	0.000158	0.000498	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL11—atopic dermatitis	0.000158	0.000498	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR2—atopic dermatitis	0.000157	0.000496	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NFKBIA—atopic dermatitis	0.000152	0.000481	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—atopic dermatitis	0.000151	0.000477	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT6—atopic dermatitis	0.000148	0.000468	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD79A—atopic dermatitis	0.000148	0.000467	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CASP8—atopic dermatitis	0.000143	0.000452	CbGpPWpGaD
Auranofin—ALB—Metabolism—GLB1—atopic dermatitis	0.000132	0.000415	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR3—atopic dermatitis	0.000129	0.000406	CbGpPWpGaD
Auranofin—ALB—Metabolism—ADSL—atopic dermatitis	0.000126	0.000398	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	0.000123	0.000389	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL18—atopic dermatitis	0.000121	0.000382	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—atopic dermatitis	0.000119	0.000376	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD4—atopic dermatitis	0.000118	0.000371	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TAC1—atopic dermatitis	0.000115	0.000362	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NPS—atopic dermatitis	0.000115	0.000362	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—atopic dermatitis	0.000113	0.000358	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD4—atopic dermatitis	0.000113	0.000356	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCR3—atopic dermatitis	0.000112	0.000355	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—atopic dermatitis	0.000111	0.000352	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL5—atopic dermatitis	0.000107	0.000336	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK8—atopic dermatitis	9.96e-05	0.000314	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.59e-05	0.000303	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NFKBIA—atopic dermatitis	9.24e-05	0.000292	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.12e-05	0.000288	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL10—atopic dermatitis	9.09e-05	0.000287	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CASP8—atopic dermatitis	8.34e-05	0.000263	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL5—atopic dermatitis	7.83e-05	0.000247	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NGF—atopic dermatitis	7.25e-05	0.000229	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNG—atopic dermatitis	7.09e-05	0.000224	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR5—atopic dermatitis	7.05e-05	0.000222	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD4—atopic dermatitis	6.85e-05	0.000216	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—atopic dermatitis	6.36e-05	0.000201	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—atopic dermatitis	6.35e-05	0.0002	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1B—atopic dermatitis	6.32e-05	0.0002	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—atopic dermatitis	6.3e-05	0.000199	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NFKBIA—atopic dermatitis	5.98e-05	0.000189	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK8—atopic dermatitis	5.8e-05	0.000183	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARA—atopic dermatitis	4.27e-05	0.000135	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL8—atopic dermatitis	4.26e-05	0.000134	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—atopic dermatitis	4.07e-05	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK8—atopic dermatitis	3.75e-05	0.000118	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—atopic dermatitis	3.7e-05	0.000117	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—atopic dermatitis	2.39e-05	7.55e-05	CbGpPWpGaD
